These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15238641)

  • 1. Pamidronate in the treatment of childhood SAPHO syndrome.
    Kerrison C; Davidson JE; Cleary AG; Beresford MW
    Rheumatology (Oxford); 2004 Oct; 43(10):1246-51. PubMed ID: 15238641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.
    Amital H; Applbaum YH; Aamar S; Daniel N; Rubinow A
    Rheumatology (Oxford); 2004 May; 43(5):658-61. PubMed ID: 14983108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.
    Solau-Gervais E; Soubrier M; Gerot I; Grange L; Puechal X; Sordet C; Sibilia J; Duquesnoy B
    Rheumatology (Oxford); 2006 Mar; 45(3):339-42. PubMed ID: 16249241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans.
    Simm PJ; Briody J; McQuade M; Munns CF
    Bone; 2010 Apr; 46(4):885-8. PubMed ID: 19969114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamidronate treatment in SAPHO syndrome.
    Guignard S; Job-Deslandre C; Sayag-Boukris V; Kahan A
    Joint Bone Spine; 2002 Jun; 69(4):392-6. PubMed ID: 12184437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
    Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
    Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of SAPHO syndrome with zoledronic acid.
    Kopterides P; Pikazis D; Koufos C
    Arthritis Rheum; 2004 Sep; 50(9):2970-3. PubMed ID: 15457466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAPHO syndrome treated with pamidronate.
    Tehrani R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):273-5. PubMed ID: 16394439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pamidronate for SAPHO syndrome.
    Crisp AJ
    Rheumatology (Oxford); 2003 Mar; 42(3):491. PubMed ID: 12626810
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature.
    Colina M; La Corte R; Trotta F
    Clin Exp Rheumatol; 2009; 27(1):112-5. PubMed ID: 19327238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate: a novel treatment for the SAPHO syndrome?
    Marshall H; Bromilow J; Thomas AL; Arden NK
    Rheumatology (Oxford); 2002 Feb; 41(2):231-3. PubMed ID: 11886977
    [No Abstract]   [Full Text] [Related]  

  • 13. SAPHO syndrome and pamidronate revisited.
    Valls-Roc M; Sanmarti M; Salles M; Holgado S; Olive A
    Rheumatology (Oxford); 2005 Jan; 44(1):137; author reply 137-8. PubMed ID: 15611315
    [No Abstract]   [Full Text] [Related]  

  • 14. SAPHO syndrome in childhood. A case report.
    Vargas Pérez M; Sevilla Pérez B
    Reumatol Clin (Engl Ed); 2018; 14(2):109-112. PubMed ID: 27993538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAPHO: rare or just not recognized?
    Van Doornum S; Barraclough D; McColl G; Wicks I
    Semin Arthritis Rheum; 2000 Aug; 30(1):70-7. PubMed ID: 10966214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
    Allington N; Vivegnis D; Gerard P
    Acta Orthop Belg; 2005 Feb; 71(1):91-7. PubMed ID: 15792214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate.
    Siau K; Laversuch CJ
    Joint Bone Spine; 2010 Mar; 77(2):176-7. PubMed ID: 20185354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible.
    Soubrier M; Dubost JJ; Ristori JM; Sauvezie B; Bussière JL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):637-40. PubMed ID: 11740481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.